The DOI matches its Crossref record; 129 of the 129 references it cites were found in a registry or an index.
The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
Open accessAbstract
The RAAS through its physiological effectors plays a key role in promoting and maintaining inflammation. Inflammation is an important mechanism in the development and progression of CVD such as hypertension and atherosclerosis. In addition to its main role in regulating blood pressure and its role in hypertension, RAAS has proinflammatory and profibrotic effects at cellular and molecular levels. Blocking RAAS provides beneficial effects for the treatment of cardiovascular and renal diseases. Evidence shows that inhibition of RAAS positively influences vascular remodeling thus improving CVD outcomes. The beneficial vascular effects of RAAS inhibition are likely due to decreasing vascular inflammation, oxidative stress, endothelial dysfunction, and positive effects on regeneration of endothelial progenitor cells. Inflammatory factors such as ICAM-1, VCAM-1, TNFα, IL-6, and CRP have key roles in mediating vascular inflammation and blocking RAAS negatively modulates the levels of these inflammatory molecules. Some of these inflammatory markers are clinically associated with CVD events. More studies are required to establish long-term effects of RAAS inhibition on vascular inflammation, vascular cells regeneration, and CVD clinical outcomes. This review presents important information on RAAS’s role on vascular inflammation, vascular cells responses to RAAS, and inhibition of RAAS signaling in the context of vascular inflammation, vascular remodeling, and vascular inflammation-associated CVD. Nevertheless, the review also equates the need to rethink and rediscover new RAAS inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eplerenone in patients with systolic heart failure and mild symptoms
Zannad, F., McMurray, J. J. V., Krum, H., van Veldhuisen, D. J., Swedberg, K., Shi, H., Vincent, J., Pocock, S. J., & Pitt, B. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009492 · Cited by 3,111 · cited 1×
“available antagonists, eplerenone and spironolactone, have been shown to be effective treatment options for hypertension and heart failure [100].”
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Rajagopalan, S., Kurz, S., Münzel, T., Tarpey, M., Freeman, B. A., Griendling, K. K., & Harrison, D. G. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118623 · Cited by 2,449
Christakis, D., Richards, J. A., Zimmerman, F. J., Garrison, M. M., Xu, D., & Yapanel, U. H. (2009) · Cited by 2,289
STUDIES ON EXPERIMENTAL HYPERTENSION
Goldblatt, H., Lynch, J., Hanzal, R. F., & Summerville, W. W. (1934) · Journal of Experimental Medicine · doi:10.1084/jem.59.3.347 · Cited by 2,142
Jonjić, S., Mutter, W., Weiland, F., Reddehase, M. J., & Koszinowski, U. H. (1989) · The Journal of experimental medicine · doi:10.1084/jem.169.4.1199 · Cited by 2,105
Pathophysiology of coronary artery disease
Libby, P., & Theroux, P. (2005) · Circulation · doi:10.1161/circulationaha.105.537878 · Cited by 1,965
Endothelial Nitric Oxide Synthase in Vascular Disease: From Marvel to Menace
Förstermann, U., & Münzel, T. (2006) · Circulation · doi:10.1161/circulationaha.105.602532 · Cited by 1,957 · cited 3×
“Mechanistically, aliskiren and valsartan combination downregulates NADPH oxidase activity and therefore attenuates oxidative stress [59], which plays a key role in initiating the development of vascular inflammation and cardiovascular disease.”
InfluentialDirect Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Pasceri, V., Willerson, J. T., & Yeh, E. T. H. (2000) · Circulation · doi:10.1161/01.cir.102.18.2165 · Cited by 1,940
Angiotensin-(1–7) is an endogenous ligand for the G protein-coupled receptor Mas
Santos, R. A. S., e Silva, A. C. S., Maric, C., Silva, D. M. R., Machado, R. P., de Buhr, I., Heringer-Walther, S., Pinheiro, S. V. B., Lopes, M. T., Bader, M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432869100 · Cited by 1,801
Tumor Necrosis Factor-α Signaling in Macrophages
Parameswaran, N., & Patial, S. (2010) · Critical Reviews™ in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v20.i2.10 · Cited by 1,437
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14276 · Cited by 1,276
Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.
Geisterfer, A. A., Peach, M. J., & Owens, G. K. (1988) · Circulation Research · doi:10.1161/01.res.62.4.749 · Cited by 1,065
Inhibitors of Angiotensin-Converting Enzyme Prevent Myointimal Proliferation After Vascular Injury
Powell, J. S., Clozel, J.-P., Müller, R. K. M., Kuhn, H., Hefti, F., Hosang, M., & Baumgartner, H. R. (1989) · Science · doi:10.1126/science.2526370 · Cited by 1,052
Reid, I. A., Morris, B. J., & Ganong, W. F. (1978) · Annual Review of Physiology · doi:10.1146/annurev.ph.40.030178.002113 · Cited by 953
Touyz, R. M., & Schiffrin, E. L. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01471-6 · Cited by 934
Brunner, H., Cockcroft, J. R., Deanfield, J., Donald, A., Ferrannini, E., Halcox, J., Kiowski, W., L??scher, T. F., Mancia, G., Natali, A., et al. (2005) · Journal of Hypertension · doi:10.1097/00004872-200502000-00001 · Cited by 753
Tissue Angiotensin and Pathobiology of Vascular Disease: A Unifying Hypothesis
Dzau, V. J. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1047 · Cited by 750
Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit.
Cooke, J. P., Singer, A. H., Tsao, P., Zera, P., Rowan, R. A., & Billingham, M. E. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115937 · Cited by 687
Interleukin-6 Overexpression Induces Pulmonary Hypertension
Steiner, M. K., Syrkina, O. L., Kolliputi, N., Mark, E. J., Hales, C. A., & Waxman, A. B. (2009) · Circulation Research · doi:10.1161/circresaha.108.182014 · Cited by 655
Renin‐angiotensin system revisited
Fyhrquist, F., & Saijonmaa, O. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01981.x · Cited by 642
Schmieder, R. E. (1996) · JAMA · doi:10.1001/jama.1996.03530430051039 · Cited by 604
Calabró, P., Willerson, J. T., & Yeh, E. T. H. (2003) · Circulation · doi:10.1161/01.cir.0000096055.62724.c5 · Cited by 566
C-Reactive Protein Upregulates Angiotensin Type 1 Receptors in Vascular Smooth Muscle
Wang, C.-H., Li, S.-H., Weisel, R. D., Fedak, P. W. M., Dumont, A. S., Szmitko, P., Li, R.-K., Mickle, D. A. G., & Verma, S. (2003) · Circulation · doi:10.1161/01.cir.0000061916.95736.e5 · Cited by 545
Verma, S., Kuliszewski, M. A., Li, S.-H., Szmitko, P. E., Zucco, L., Wang, C.-H., Badiwala, M. V., Mickle, D. A. G., Weisel, R. D., Fedak, P. W. M., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127577.63323.24 · Cited by 525
Santos, R. A. S., Ferreira, A. J., Verano-Braga, T., & Bader, M. (2013) · Journal of Endocrinology · doi:10.1530/joe-12-0341 · Cited by 523
Pueyo, M. E., Gonzalez, W., Nicoletti, A., Savoie, F., Arnal, J.-F., & Michel, J.-B. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.3.645 · Cited by 517
Ferrario, C. M., & Strawn, W. B. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2006.01.059 · Cited by 512
Angiotensin Induces Inflammatory Activation of Human Vascular Smooth Muscle Cells
Kranzhöfer, R., Schmidt, J., Pfeiffer, C. A. H., Hagl, S., Libby, P., & Kübler, W. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.7.1623 · Cited by 480
Itoh, H., Mukoyama, M., Pratt, R. E., Gibbons, G. H., & Dzau, V. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116454 · Cited by 469
Recent advances in the angiotensin‐converting enzyme 2–angiotensin(1–7)–Mas axis
Santos, R. A. S., Ferreira, A. J., & Simões e Silva, A. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2008.042002 · Cited by 432
Chen, X.-L., Tummala, P. E., Olbrych, M. T., Alexander, R. W., & Medford, R. M. (1998) · Circulation Research · doi:10.1161/01.res.83.9.952 · Cited by 385
Tummala, P. E., Chen, X.-L., Sundell, C. L., Laursen, J. B., Hammes, C. P., Alexander, R. W., Harrison, D. G., & Medford, R. M. (1999) · Circulation · doi:10.1161/01.cir.100.11.1223 · Cited by 379
Han, Y., Runge, M. S., & Brasier, A. R. (1999) · Circulation Research · doi:10.1161/01.res.84.6.695 · Cited by 377
Pollman, M. J., Yamada, T., Horiuchi, M., & Gibbons, G. H. (1996) · Circulation Research · doi:10.1161/01.res.79.4.748 · Cited by 341
Park, J. B., & Schiffrin, E. L. (2001) · Journal of Hypertension · doi:10.1097/00004872-200105000-00013 · Cited by 325
Regulation of Aldosterone Secretion
Quinn, S. J., & Williams, G. H. (1988) · Annual Review of Physiology · doi:10.1146/annurev.ph.50.030188.002205 · Cited by 313
THE LIVER AS THE SITE OF C-REACTIVE PROTEIN FORMATION
Hurlimann, J., Thorbecke, G. J., & Hochwald, G. M. (1966) · The Journal of Experimental Medicine · doi:10.1084/jem.123.2.365 · Cited by 311
Oparil, S., & Haber, E. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408222910805 · Cited by 308
Effects of Aldosterone on the Vasculature
Schiffrin, E. L. (2006) · Hypertension · doi:10.1161/01.hyp.0000201443.63240.a7 · Cited by 303
Judkins, C. P., Diep, H., Broughton, B. R. S., Mast, A. E., Hooker, E. U., Miller, A. A., Selemidis, S., Dusting, G. J., Sobey, C. G., & Drummond, G. R. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00799.2009 · Cited by 299
Caprio, M., Newfell, B. G., la Sala, A., Baur, W., Fabbri, A., Rosano, G., Mendelsohn, M. E., & Jaffe, I. Z. (2008) · Circulation Research · doi:10.1161/circresaha.108.174235 · Cited by 285
Staessen, J. A., Li, Y., & Richart, T. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69442-7 · Cited by 284
Sola, S., Mir, M. Q. S., Cheema, F. A., Khan-Merchant, N., Menon, R. G., Parthasarathy, S., & Khan, B. V. (2005) · Circulation · doi:10.1161/01.cir.0000153272.48711.b9 · Cited by 282
Brilla, C. G., Matsubara, L. S., & Weber, K. T. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90239-9 · Cited by 278
Rohde, L. E., Lee, R. T., Rivero, J., Jamacochian, M., Arroyo, L. H., Briggs, W., Rifai, N., Libby, P., Creager, M. A., & Ridker, P. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1765 · Cited by 260
Dzau, V. J., Bernstein, K., Celermajer, D., Cohen, J., Dahlöf, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01878-1 · Cited by 259
Bahlmann, F. H., de Groot, K., Mueller, O., Hertel, B., Haller, H., & Fliser, D. (2005) · Hypertension · doi:10.1161/01.hyp.0000159191.98140.89 · Cited by 259
Tumor Necrosis Factor-α Induces Endothelial Dysfunction in Lepr db Mice
Gao, X., Belmadani, S., Picchi, A., Xu, X., Potter, B. J., Tewari-Singh, N., Capobianco, S., Chilian, W. M., & Zhang, C. (2007) · Circulation · doi:10.1161/circulationaha.106.650671 · Cited by 241
Ferrario, C. M. (2006) · Hypertension · doi:10.1161/01.hyp.0000196268.08909.fb · Cited by 241
Risk factors for coronary heart disease and acute-phase proteins. A population-based study
Danesh, J. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1309 · Cited by 240
Huang, Y., Noble, N. A., Zhang, J., Xu, C., & Border, W. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002243 · Cited by 235
Zhong, J., Guo, D., Chen, C. B., Wang, W., Schuster, M., Loibner, H., Penninger, J. M., Scholey, J. W., Kassiri, Z., & Oudit, G. Y. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.164244 · Cited by 233
Calhoun, D. A., White, W. B., Krum, H., Guo, W., Bermann, G., Trapani, A., Lefkowitz, M. P., & Ménard, J. (2011) · Circulation · doi:10.1161/circulationaha.111.029892 · Cited by 227 · cited 1×
“In clinical trials, administration of LCI699 has been shown to reduce plasma and urine aldosterone level in participants with sodium-depleted levels, to lower blood pressure in patients with essential hypertension and to balance hypokalemia in patients with aldosteronism [110, 114, 115].”
Mombouli, J. V., Illiano, S., Nagao, T., Scott-Burden, T., & Vanhoutte, P. M. (1992) · Circulation Research · doi:10.1161/01.res.71.1.137 · Cited by 223
Fujita, M., Shannon, J. M., Irvin, C. G., Fagan, K. A., Cool, C., Augustin, A., & Mason, R. J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.1.l39 · Cited by 223
Activation of human peripheral monocytes by angiotensin II
Hahn, A. W. A., Jonas, U., Bühler, F. R., & Resink, T. J. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00531-1 · Cited by 209
Dandona, P., Kumar, V., Aljada, A., Ghanim, H., Syed, T., Hofmayer, D., Mohanty, P., Tripathy, D., & Garg, R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021836 · Cited by 207
Landry, D. B., Couper, L. L., Bryant, S. R., & Lindner, V. (1997) · PubMed Central · Cited by 205
Amar, L., Azizi, M., Menard, J., Peyrard, S., Watson, C., & Plouin, P.-F. (2010) · Hypertension · doi:10.1161/hypertensionaha.110.157271 · Cited by 202
Bomfim, G. F., Santos, R. A. D., Oliveira, M. A., Giachini, F. R., Akamine, E. H., Tostes, R. C., Fortes, Z. B., Webb, R. C., & Carvalho, M. H. C. (2012) · Clinical Science · doi:10.1042/cs20110523 · Cited by 201
A New Mode of Mineralocorticoid Receptor Antagonism by a Potent and Selective Nonsteroidal Molecule
Fagart, J., Hillisch, A., Huyet, J., Bärfacker, L., Fay, M., Pleiss, U., Pook, E., Schäfer, S., Rafestin-Oblin, M.-E., & Kolkhof, P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.131342 · Cited by 191
Direct evidence of leukocyte adhesion in arterioles by angiotensin II
Álvarez, A., Cerdá-Nicolás, M., Naim Abu Nabah, Y., Mata, M., Issekutz, A. C., Panés, J., Lobb, R. R., & Sanz, M.-J. (2004) · Blood · doi:10.1182/blood-2003-08-2974 · Cited by 181
Mineralocorticoid receptors in vascular function and disease
McCurley, A., & Jaffe, I. Z. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.014 · Cited by 178
Min, T. Q., Zhu, C. J., Xiang, W. X., Hui, Z., & Peng, S. Y. (2004) · Cardiovascular Drugs and Therapy · doi:10.1023/b:card.0000033641.33503.bd · Cited by 175
Inflammation in Cardiovascular Disease: Cart, Horse, or Both?
Tracy, R. P. (1998) · Circulation · doi:10.1161/01.cir.97.20.2000 · Cited by 162
Shahin, Y., Khan, J. A., Samuel, N., & Chetter, I. C. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.02.044 · Cited by 152
In Vitro Evidence for an Intracellular Site of Angiotensin Action
Cook, J. L., Zhang, Z., & Ré, R. N. (2001) · Circulation Research · doi:10.1161/hh2401.101270 · Cited by 144
The Putative (Pro)renin Receptor Blocker HRP Fails to Prevent (Pro)renin Signaling
Feldt, S., Maschke, U., Dechend, R., Luft, F. C., & Müller, D. N. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091030 · Cited by 140
Russo, G., Leopold, J. A., & Loscalzo, J. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00250-1 · Cited by 136
Mulder, P. G. H., Mellin, V., Favre, J., Vercauteren, M., Rémy‐Jouet, I., Monteil, C., Richard, V. J., Renet, S., Henry, J. P., Jeng, A. Y., et al. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn277 · Cited by 126
Mj, B. (2008) · Circulation · doi:10.1161/circulationaha.108.787630 · Cited by 125
Pathophysiological regulation of the AT1-receptor and implications for vascular disease
Waßmann, S., & Nickenig, G. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000220402.53869.72 · Cited by 124
von Känel, R., Mills, P. J., Mausbach, B. T., Dimsdale, J. E., Patterson, T. L., Ziegler, M. G., Ancoli‐Israel, S., Allison, M., Chattillion, E. A., & Grant, I. (2011) · Gerontology · doi:10.1159/000334219 · Cited by 121
Lea, W. B., Kwak, E. S., Luther, J. M., Fowler, S. M., Wang, Z., Ma, J., Fogo, A. B., & Brown, N. J. (2009) · Kidney International · doi:10.1038/ki.2009.9 · Cited by 118
Schmieder, R. E. (1996) · JAMA · doi:10.1001/jama.275.19.1507 · Cited by 118
Towards the understanding of the local hematopoietic bone marrow renin-angiotensin system
Haznedaroğlu, İ. C., & Öztürk, M. A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00278-9 · Cited by 113
Empana, J. P., Jouven, X., Canouï‐Poitrine, F., Luc, G., Tafflet, M., Haas, B., Arveiler, D., Ferrières, J., Ruidavets, J., Montaye, M., et al. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.208785 · Cited by 111
(Pro)renin receptor contributes to diabetic nephropathy by enhancing renal inflammation
Matavelli, L. C., Huang, J., & Siragy, H. M. (2009) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2009.05292.x · Cited by 105
Study of Aldosterone Synthase Inhibition as an Add‐On Therapy in Resistant Hypertension
Karns, A. D., Bral, J. M., Hartman, D., Peppard, T., & Schumacher, C. (2013) · The Journal of Clinical Hypertension · doi:10.1111/jch.12051 · Cited by 104
Angiotensin-(1–7) Attenuates Neointimal Formation After Stent Implantation in the Rat
Langeveld, B., van Gilst, W. H., Tio, R. A., Zijlstra, F., & Roks, A. J. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000149382.83973.c2 · Cited by 100
Meyers, M. J., Arhancet, G. B., Hockerman, S. L., Chen, X., Long, S. A., Mahoney, M. W., Rico, J. R., Garland, D. J., Blinn, J. R., Collins, J. T., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100505n · Cited by 97
Oparil, S., & Haber, E. (1974) · New England Journal of Medicine · doi:10.1056/nejm197408292910905 · Cited by 91
Qi, G., Jia, L., Li, Y., Bian, Y., Cheng, J., Li, H., Xiao, C., & Du, J. (2011) · Cardiovascular Toxicology · doi:10.1007/s12012-011-9109-z · Cited by 89
Nguyen, G., Delarue, F., Burcklé, C., Bouzhir-Sima, L., Giller, T., & Sraer, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214276 · Cited by 88
Maejima, Y., Okada, H., Haraguchi, G., Onai, Y., Kosuge, H., Suzuki, J., & Isobe, M. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.45 · Cited by 86
Widespread tissue distribution of human chymase.
Urata, H., Strobel, F., & Ganten, D. (1994) · PubMed · Cited by 85
Masiha, S., Sundström, J., & Lind, L. (2012) · Journal of Human Hypertension · doi:10.1038/jhh.2011.113 · Cited by 82
Li, Z., Iwai, M., Wu, L., Liu, H., Chen, R., Jinno, T., Suzuki, J., Tsuda, M., Gao, X.-Y., Okumura, M., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000145179.44166.0f · Cited by 81
Mineralocorticoid receptor‐mediated DNA damage in kidneys of DOCA‐salt hypertensive rats
Schupp, N., Kolkhof, P., Queisser, N., Gärtner, S., Schmid, U., Kretschmer, A., Hartmann, E., Oli, R. G., Schäfer, S., & Stopper, H. (2010) · The FASEB Journal · doi:10.1096/fj.10-173286 · Cited by 76
Richard, V. J., Hurel-Merle, S., Scalbert, E., Ferry, G., Lallemand, F., Bessou, J., & Thuillez, C. (2001) · Circulation · doi:10.1161/hc3201.094971 · Cited by 76
Sherajee, S. J., Fujita, Y., Rafiq, K., Nakano, D., Mori, H., Masaki, T., Hara, T., Kohno, M., Nishiyama, A., & Hitomi, H. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.240697 · Cited by 73
Human cytokines modulate arterial vascular tone via endothelial receptors
Iversen, P., Nicolaysen, A., Kvernebo, K., Benestad, H. B., & Nicolaysen, G. (1999) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s004249900149 · Cited by 69
Effect of vasoactive peptides on prostacyclin synthesis in man
Barrow, S. E., Dollery, C. T., Heavey, D. J., Hickling, N. E., Ritter, J. M., & Vial, J. H. (1986) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1986.tb10177.x · Cited by 66
Davie, A. P., & McMurray, J. J. V. (1999) · Hypertension · doi:10.1161/01.hyp.34.3.457 · Cited by 65
Thum, T., Schmitter, K., Fleißner, F., Wiebking, V., Dietrich, B., Widder, J. D., Jazbutyte, V., Hahner, S., Ertl, G., & Bauersachs, J. K. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq254 · Cited by 60
Investigation of aldosterone-synthase inhibition in rats
Ménard, J., Gonzalez, M.-F., Guyene, T.-T., & Bissery, A. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000226205.65442.f2 · Cited by 57
Synthesis, characterization and antioxidant activity of angiotensin converting enzyme inhibitors
Bhuyan, B. J., & Mugesh, G. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00823k · Cited by 54
Takahashi, K., Yamamoto, H., Hirose, T., Hiraishi, K., Shoji, I., Shibasaki, A., Kato, I., Kaneko, K., Sasano, H., Satoh, F., et al. (2010) · Peptides · doi:10.1016/j.peptides.2010.04.003 · Cited by 52
Endothelial Damage and Regeneration: The Role of the Renin-Angiotensin-Aldosterone System
Becher, U. M., Endtmann, C., Tiyerili, V., Nickenig, G., & Werner, N. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0171-x · Cited by 52
Aldosterone Impairs Bone Marrow–Derived Progenitor Cell Formation
Marumo, T., Uchimura, H., Hayashi, M., Hishikawa, K., & Fujita, T. (2006) · Hypertension · doi:10.1161/01.hyp.0000235681.25685.cf · Cited by 52
Yamada, T., Kondo, T., Numaguchi, Y., Tsuzuki, M., Matsubara, T., Manabe, I., Sata, M., Nagai, R., & Murohara, T. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.147124 · Cited by 51
Mason (2011) · Vascular Health and Risk Management · doi:10.2147/vhrm.s20737 · Cited by 49
Liu, G., Hitomi, H., Hosomi, N., Shibayama, Y., Nakano, D., Kiyomoto, H., Ma, H., Yamaji, Y., Kohno, M., Ichihara, A., et al. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e328343c62b · Cited by 48
Krasinski, K. L., Spyridopoulos, I., Kearney, M., & Losordo, D. W. (2001) · Circulation · doi:10.1161/hc4001.098046 · Cited by 47
C-Reactive Protein-Mediated Vascular Injury Requires Complement
Hage, F. G., Oparil, S., Xing, D., Chen, Y.-F., McCrory, M. A., & Szalai, A. J. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.205377 · Cited by 45
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Oparil, S. (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s4291 · Cited by 44
van Esch, J. H. M., van Veghel, R., Garrelds, I. M., Leijten, F. P. J., Bouhuizen, A. M., & Danser, A. H. J. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.169060 · Cited by 44
Lack of TNF-α attenuates intimal hyperplasia after mouse carotid artery injury
Zimmerman, M. A., Selzman, C. H., Reznikov, L. L., Miller, S. A., Raeburn, C. D., Emmick, J., Meng, X., & Harken, A. H. (2002) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00033.2002 · Cited by 43
Gul, R., Shawl, A. I., Kim, S.-H., & Kim, U. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00250.2011 · Cited by 41
Aldosterone Inhibition and Cardiovascular Protection: More Important Than it Once Appeared
Martínez, F. A. (2010) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-010-6256-6 · Cited by 39
Ménard, J., Watson, C. E., Rebello, S. S., Zhang, Y. M., & Dole, W. P. (2010) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(10)60584-0 · Cited by 38
Rajamohan, S. B., Raghuraman, G., Prabhakar, N. R., & Kumar, G. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4176 · Cited by 37
Autocrine and Paracrine Function of Angiotensin 1-7 in Tissue Repair During Hypertension
Meng, W., Zhao, W., Zhao, T., Liu, C., Chen, Y., Liu, H., & Sun, Y. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpt270 · Cited by 35
Hasui, T., Ohra, T., Ohyabu, N., Asano, K., Matsui, H., Mizukami, A., Habuka, N., Sogabe, S., Endo, S., Siedem, C. S., et al. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.07.043 · Cited by 34
Kühnast, S., van der Hoorn, J. W. A., van den Hoek, A. M., Havekes, L. M., Liau, G., Jukema, J. W., & Princen, H. M. G. (2011) · Journal of Hypertension · doi:10.1097/hjh.0b013e32834ddd8e · Cited by 34
Cascella, T., Radhakrishnan, Y., Maile, L. A., Busby, W. H., Gollahon, K. A., Colao, A., & Clemmons, D. R. (2010) · Endocrinology · doi:10.1210/en.2010-0350 · Cited by 31
Antioxidant activity of peptide-based angiotensin converting enzyme inhibitors
Bhuyan, B. J., & Mugesh, G. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob06533a · Cited by 31
Kyotani, Y., Zhao, J., Tomita, S., Nakayama, H., Isosaki, M., Uno, M., & Yoshizumi, M. (2010) · Journal of Pharmacological Sciences · doi:10.1254/jphs.09332fp · Cited by 29
Sonoda, M., Aoyagi, T., Takenaka, K., Uno, K., & Nagai, R. (2008) · International Heart Journal · doi:10.1536/ihj.49.95 · Cited by 27
Niida, T., Isoda, K., Kitagaki, M., Ishigami, N., Adachi, T. K., Matsubara, O., Takeda, K., Kishimoto, T., & Ohsuzu, F. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr323 · Cited by 22
Tang, W., Zhou, Y.-Q., Zhao, T., Shan, J.-L., Sun, P. G., Yang, T., Chang, X.-W., Li, S., Wang, P. S., & Xie, D. (2012) · The Chinese Journal of Physiology · doi:10.4077/cjp.2011.amm069 · Cited by 22
Tumor necrosis factor inhibitors as novel therapeutic tools for vascular remodeling diseases
Lambert, C. M., Roy, M., Meloche, J., Robitaille, G., Agharazii, M., Richard, D. E., & Bonnet, S. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00562.2010 · Cited by 18
Caprio, M., Mammi, C., Jaffe, I. Z., Zennaro, M., Aversa, A., Mendelsohn, M. E., Fabbri, A., & Rosano, G. M. C. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786898743 · Cited by 17
LECKIE, B. J., & Bottrill, A. R. (2010) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320310370610 · Cited by 12
Mansur, S. J., Hage, F. G., & Oparil, S. (2010) · Current Cardiology Reports · doi:10.1007/s11886-010-0140-7 · Cited by 11
Targeting the aldosterone pathway in cardiovascular disease
Gustafsson, F., Azizi, M., Bauersachs, J. K., Jaisser, F., & Rossignol, P. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.01004.x · Cited by 9
Aliskiren displays long-lasting interactions with human renin
Gossas, T., Vrang, L., Henderson, I. M., Sedig, S., Sahlberg, C., Lindström, E., & Danielson, U. H. (2011) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-011-0718-7 · Cited by 8
Yamauchi, J., Shibagaki, Y., Uehara, K., Yasuda, T., & Kimura, K. (2011) · Clinical and Experimental Nephrology · doi:10.1007/s10157-011-0566-2 · Cited by 6
Cited by
Siti, H. N., Kamisah, Y., & Kamsiah, J. (2015) · Vascular Pharmacology · doi:10.1016/j.vph.2015.03.005 · Cited by 898
Free radicals and their impact on health and antioxidant defenses: a review
Chandimali, N., Bak, S. G., Park, E. H., Lim, H.-J., Won, Y.-S., Kim, E.-K., Park, S.-I., & Lee, S. J. (2025) · Cell Death Discovery · doi:10.1038/s41420-024-02278-8 · Cited by 669
How Western Diet And Lifestyle Drive The Pandemic Of Obesity And Civilization Diseases
Kopp, W. (2019) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s216791 · Cited by 660
COVID-19 cytokine storm: the anger of inflammation
Mahmudpour, M., Roozbeh, J., Keshavarz, M., Farrokhi, S., & Nabipour, I. (2020) · Cytokine · doi:10.1016/j.cyto.2020.155151 · Cited by 461
“This elegant system also plays a significant role in the promotion and maintenance of inflammation [18].”
Vascular smooth muscle cell in atherosclerosis
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2015) · Acta Physiologica · doi:10.1111/apha.12466 · Cited by 384
Metadata
- Authors
- Pacurari, M., Kafoury, R., Tchounwou, P. B., & Ndebele, K.
- Venue
- International Journal of Inflammation
- Publisher
- Wiley
- Published
- 2014
- Volume
- 2014
- Pages
- 1-13
- ISSN
- 2042-0099 (ISSN-L)
- 2090-8040
- OpenAlex
- W2051926037
- Cited by
- 374
- References
- 129
- FWCI
- 20.85
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.